Abstract: ObjectiveTo investigate the clinical significance of microRNA375(miR375) expression in nasopharyngeal carcinoma (NPC) and its impact on NPC cells.Methods67 NPC specimens and 53 chronic pharyngitis specimens were collected. Realtime fluorescence quantitative polymerase chain reaction (qRTPCR) was used to detect the expression of miR375 in the specimens, CNE1, CNE2, C6661 and NP69 (an immortalized nasopharyngeal epithelial cells line) cells lines. All the cells were transfected with miR375 mimics or inhibitors respectively. Cell proliferation was detected by CCK8 assay kit and cell migration by transwell assay. Bioinformatics software was adopted to predict the target gene of miR375, and the expression of the target gene was verified by Western blot and dual luciferase assay.ResultsThe expression of miR375 in NPC specimens was markedly downregulated compared to that in the chronic pharyngitis tissues (P<0.05). The expression level of miR375 was correlated with the size, lymph node metastasis and clinic stage of tumor (all P<0.05), but had no correlation with the patients' age, gender and smoking history, histologic type and differentiation degree of the tumor (all P>0.05). The expression levels of miR375 in the 4 types of NPC cells were significantly lower than that in the NP69 cell (all P<0.05). After overexpression of miR375, proliferation and migration abilities of C6661 cell were significantly lower than those of the chronic pharyngitis tissues (both P<0.05), and NLK expression was downregulated. After suppression of miR375, the abilities of CNE1 cell were significantly higher than those of the chronic pharyngitis tissues (both P<0.05), and NLK expression was upregulated. The miR375 targeted regulation on the NLK directly.ConclusionThe expression of miR375 is downregulated in NPC, which is correlated with the size, regional lymph node involvement and clinic stage of the tumor. miR375 may inhibit the proliferation and migration of NPC cells by downregulating its target NLK gene.